Developing Potential Candidates of Preclinical Preeclampsia
AbstractThe potential for developing molecules of interest in preclinical preeclampsia from candidate genes that were discovered on gene expression microarray analysis has been challenged by limited access to additional first trimester trophoblast and decidual tissues. The question of whether these candidates encode secreted proteins that may be detected in maternal circulation early in pregnancy has been investigated using various proteomic methods. Pilot studies utilizing mass spectrometry based proteomic assays, along with enzyme linked immunosorbent assays (ELISAs), and Western immunoblotting in first trimester samples are reported. The novel targeted mass spectrometry methods led to robust multiple reaction monitoring assays. Despite detection of several candidates in early gestation, challenges persist. Future antibody-based studies may lead to a novel multiplex protein panel for screening or detection to prevent or mitigate preeclampsia. View Full-Text
Share & Cite This Article
Founds, S.; Zeng, X.; Lykins, D.; Roberts, J.M. Developing Potential Candidates of Preclinical Preeclampsia. Int. J. Mol. Sci. 2015, 16, 27208-27227.
Founds S, Zeng X, Lykins D, Roberts JM. Developing Potential Candidates of Preclinical Preeclampsia. International Journal of Molecular Sciences. 2015; 16(11):27208-27227.Chicago/Turabian Style
Founds, Sandra; Zeng, Xuemei; Lykins, David; Roberts, James M. 2015. "Developing Potential Candidates of Preclinical Preeclampsia." Int. J. Mol. Sci. 16, no. 11: 27208-27227.